Media Release
Company statement on Tocilizumab (Brand: Actemra) supplies
V. Simpson Emmanuel appointed as General Manager, Roche Products (India) Pvt. Ltd.
Roche launches new therapy Emicizumab for people with Hemophilia A on World Hemophilia Day
Roche Pharma India partners with Cipla to create greater access to key medicines
Providing confidence and support to patients
Roche India’s "The Blue Tree" program offers support to cancer patients during their treatment journey, from diagnosis till completion of therapy.It is a patient support initiative that is designed to take care of the multiple hurdles that a patient has to go through during the course of receiving treatment. Read more
Approval of biosimilars must be subject to rigorous clinical and regulatory standards.
In order to ensure patients and physicians can make informed treatment decisions, it is critical that they have full access to information about products claiming to be similar to or a biosimilar of innovative biologics, and clarity on whether or not they have met the requirements for biosimilar products. Read more
Company Statement: Delhi High Court Interim Order, March 03, 2017